NanotechnologyCancer Treatment and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Nanotechnology in Cancer Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nanotechnology in Cancer Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nanotechnology in Cancer Treatment Overall Market Size
2.1 Global Nanotechnology in Cancer Treatment Market Size: 2021 VS 2028
2.2 Global Nanotechnology in Cancer Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Nanotechnology in Cancer Treatment Players in Global Market
3.2 Top Global Nanotechnology in Cancer Treatment Companies Ranked by Revenue
3.3 Global Nanotechnology in Cancer Treatment Revenue by Companies
3.4 Top 3 and Top 5 Nanotechnology in Cancer Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Nanotechnology in Cancer Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Nanotechnology in Cancer Treatment Players in Global Market
3.6.1 List of Global Tier 1 Nanotechnology in Cancer Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Nanotechnology in Cancer Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Nanotechnology in Cancer Treatment Market Size Markets, 2021 & 2028
4.1.2 Nanoparticles
4.1.3 Nanorods
4.1.4 Nanofibers
4.1.5 Graphene
4.1.6 Metal-Organic Frameworks
4.1.7 Nanobiosensors
4.1.8 Nanofluidic Devices
4.1.9 Nanotools
4.2 By Type - Global Nanotechnology in Cancer Treatment Revenue & Forecasts
4.2.1 By Type - Global Nanotechnology in Cancer Treatment Revenue, 2017-2022
4.2.2 By Type - Global Nanotechnology in Cancer Treatment Revenue, 2023-2028
4.2.3 By Type - Global Nanotechnology in Cancer Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Nanotechnology in Cancer Treatment Market Size, 2021 & 2028
5.1.2 Cancer Detection
5.1.3 Imaging
5.1.4 Drug Delivery
5.1.5 Radiotherapy
5.1.6 Immunotherapy
5.1.7 Phototherapy
5.2 By Application - Global Nanotechnology in Cancer Treatment Revenue & Forecasts
5.2.1 By Application - Global Nanotechnology in Cancer Treatment Revenue, 2017-2022
5.2.2 By Application - Global Nanotechnology in Cancer Treatment Revenue, 2023-2028
5.2.3 By Application - Global Nanotechnology in Cancer Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Nanotechnology in Cancer Treatment Market Size, 2021 & 2028
6.2 By Region - Global Nanotechnology in Cancer Treatment Revenue & Forecasts
6.2.1 By Region - Global Nanotechnology in Cancer Treatment Revenue, 2017-2022
6.2.2 By Region - Global Nanotechnology in Cancer Treatment Revenue, 2023-2028
6.2.3 By Region - Global Nanotechnology in Cancer Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Nanotechnology in Cancer Treatment Revenue, 2017-2028
6.3.2 US Nanotechnology in Cancer Treatment Market Size, 2017-2028
6.3.3 Canada Nanotechnology in Cancer Treatment Market Size, 2017-2028
6.3.4 Mexico Nanotechnology in Cancer Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Nanotechnology in Cancer Treatment Revenue, 2017-2028
6.4.2 Germany Nanotechnology in Cancer Treatment Market Size, 2017-2028
6.4.3 France Nanotechnology in Cancer Treatment Market Size, 2017-2028
6.4.4 U.K. Nanotechnology in Cancer Treatment Market Size, 2017-2028
6.4.5 Italy Nanotechnology in Cancer Treatment Market Size, 2017-2028
6.4.6 Russia Nanotechnology in Cancer Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Nanotechnology in Cancer Treatment Market Size, 2017-2028
6.4.8 Benelux Nanotechnology in Cancer Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Nanotechnology in Cancer Treatment Revenue, 2017-2028
6.5.2 China Nanotechnology in Cancer Treatment Market Size, 2017-2028
6.5.3 Japan Nanotechnology in Cancer Treatment Market Size, 2017-2028
6.5.4 South Korea Nanotechnology in Cancer Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Nanotechnology in Cancer Treatment Market Size, 2017-2028
6.5.6 India Nanotechnology in Cancer Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Nanotechnology in Cancer Treatment Revenue, 2017-2028
6.6.2 Brazil Nanotechnology in Cancer Treatment Market Size, 2017-2028
6.6.3 Argentina Nanotechnology in Cancer Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Nanotechnology in Cancer Treatment Revenue, 2017-2028
6.7.2 Turkey Nanotechnology in Cancer Treatment Market Size, 2017-2028
6.7.3 Israel Nanotechnology in Cancer Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Nanotechnology in Cancer Treatment Market Size, 2017-2028
6.7.5 UAE Nanotechnology in Cancer Treatment Market Size, 2017-2028
7 Players Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Corporate Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Nanotechnology in Cancer Treatment Major Product Offerings
7.1.4 Abbott Laboratories Nanotechnology in Cancer Treatment Revenue in Global Market (2017-2022)
7.1.5 Abbott Laboratories Key News
7.2 Combimatrix Corporation
7.2.1 Combimatrix Corporation Corporate Summary
7.2.2 Combimatrix Corporation Business Overview
7.2.3 Combimatrix Corporation Nanotechnology in Cancer Treatment Major Product Offerings
7.2.4 Combimatrix Corporation Nanotechnology in Cancer Treatment Revenue in Global Market (2017-2022)
7.2.5 Combimatrix Corporation Key News
7.3 GE Healthcare
7.3.1 GE Healthcare Corporate Summary
7.3.2 GE Healthcare Business Overview
7.3.3 GE Healthcare Nanotechnology in Cancer Treatment Major Product Offerings
7.3.4 GE Healthcare Nanotechnology in Cancer Treatment Revenue in Global Market (2017-2022)
7.3.5 GE Healthcare Key News
7.4 Sigma-Tau Pharmaceuticals Inc.
7.4.1 Sigma-Tau Pharmaceuticals Inc. Corporate Summary
7.4.2 Sigma-Tau Pharmaceuticals Inc. Business Overview
7.4.3 Sigma-Tau Pharmaceuticals Inc. Nanotechnology in Cancer Treatment Major Product Offerings
7.4.4 Sigma-Tau Pharmaceuticals Inc. Nanotechnology in Cancer Treatment Revenue in Global Market (2017-2022)
7.4.5 Sigma-Tau Pharmaceuticals Inc. Key News
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Corporate Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Nanotechnology in Cancer Treatment Major Product Offerings
7.5.4 Johnson & Johnson Nanotechnology in Cancer Treatment Revenue in Global Market (2017-2022)
7.5.5 Johnson & Johnson Key News
7.6 Mallinckrodt Plc
7.6.1 Mallinckrodt Plc Corporate Summary
7.6.2 Mallinckrodt Plc Business Overview
7.6.3 Mallinckrodt Plc Nanotechnology in Cancer Treatment Major Product Offerings
7.6.4 Mallinckrodt Plc Nanotechnology in Cancer Treatment Revenue in Global Market (2017-2022)
7.6.5 Mallinckrodt Plc Key News
7.7 Merck & Company Inc.
7.7.1 Merck & Company Inc. Corporate Summary
7.7.2 Merck & Company Inc. Business Overview
7.7.3 Merck & Company Inc. Nanotechnology in Cancer Treatment Major Product Offerings
7.7.4 Merck & Company Inc. Nanotechnology in Cancer Treatment Revenue in Global Market (2017-2022)
7.7.5 Merck & Company Inc. Key News
7.8 Nanosphere Inc.
7.8.1 Nanosphere Inc. Corporate Summary
7.8.2 Nanosphere Inc. Business Overview
7.8.3 Nanosphere Inc. Nanotechnology in Cancer Treatment Major Product Offerings
7.8.4 Nanosphere Inc. Nanotechnology in Cancer Treatment Revenue in Global Market (2017-2022)
7.8.5 Nanosphere Inc. Key News
7.9 Pfizer, Inc.
7.9.1 Pfizer, Inc. Corporate Summary
7.9.2 Pfizer, Inc. Business Overview
7.9.3 Pfizer, Inc. Nanotechnology in Cancer Treatment Major Product Offerings
7.9.4 Pfizer, Inc. Nanotechnology in Cancer Treatment Revenue in Global Market (2017-2022)
7.9.5 Pfizer, Inc. Key News
7.10 Celgene Corporation
7.10.1 Celgene Corporation Corporate Summary
7.10.2 Celgene Corporation Business Overview
7.10.3 Celgene Corporation Nanotechnology in Cancer Treatment Major Product Offerings
7.10.4 Celgene Corporation Nanotechnology in Cancer Treatment Revenue in Global Market (2017-2022)
7.10.5 Celgene Corporation Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Nanotechnology in Cancer Treatment Market Opportunities & Trends in Global Market
Table 2. Nanotechnology in Cancer Treatment Market Drivers in Global Market
Table 3. Nanotechnology in Cancer Treatment Market Restraints in Global Market
Table 4. Key Players of Nanotechnology in Cancer Treatment in Global Market
Table 5. Top Nanotechnology in Cancer Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Nanotechnology in Cancer Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Nanotechnology in Cancer Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Nanotechnology in Cancer Treatment Product Type
Table 9. List of Global Tier 1 Nanotechnology in Cancer Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nanotechnology in Cancer Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Nanotechnology in Cancer Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Nanotechnology in Cancer Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Nanotechnology in Cancer Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Nanotechnology in Cancer Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Nanotechnology in Cancer Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Nanotechnology in Cancer Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Nanotechnology in Cancer Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Nanotechnology in Cancer Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Nanotechnology in Cancer Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Nanotechnology in Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Nanotechnology in Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Nanotechnology in Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Nanotechnology in Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Nanotechnology in Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Nanotechnology in Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Nanotechnology in Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Nanotechnology in Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Nanotechnology in Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Nanotechnology in Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Laboratories Corporate Summary
Table 31. Abbott Laboratories Nanotechnology in Cancer Treatment Product Offerings
Table 32. Abbott Laboratories Nanotechnology in Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Combimatrix Corporation Corporate Summary
Table 34. Combimatrix Corporation Nanotechnology in Cancer Treatment Product Offerings
Table 35. Combimatrix Corporation Nanotechnology in Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 36. GE Healthcare Corporate Summary
Table 37. GE Healthcare Nanotechnology in Cancer Treatment Product Offerings
Table 38. GE Healthcare Nanotechnology in Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Sigma-Tau Pharmaceuticals Inc. Corporate Summary
Table 40. Sigma-Tau Pharmaceuticals Inc. Nanotechnology in Cancer Treatment Product Offerings
Table 41. Sigma-Tau Pharmaceuticals Inc. Nanotechnology in Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Johnson & Johnson Corporate Summary
Table 43. Johnson & Johnson Nanotechnology in Cancer Treatment Product Offerings
Table 44. Johnson & Johnson Nanotechnology in Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Mallinckrodt Plc Corporate Summary
Table 46. Mallinckrodt Plc Nanotechnology in Cancer Treatment Product Offerings
Table 47. Mallinckrodt Plc Nanotechnology in Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Merck & Company Inc. Corporate Summary
Table 49. Merck & Company Inc. Nanotechnology in Cancer Treatment Product Offerings
Table 50. Merck & Company Inc. Nanotechnology in Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Nanosphere Inc. Corporate Summary
Table 52. Nanosphere Inc. Nanotechnology in Cancer Treatment Product Offerings
Table 53. Nanosphere Inc. Nanotechnology in Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Pfizer, Inc. Corporate Summary
Table 55. Pfizer, Inc. Nanotechnology in Cancer Treatment Product Offerings
Table 56. Pfizer, Inc. Nanotechnology in Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Celgene Corporation Corporate Summary
Table 58. Celgene Corporation Nanotechnology in Cancer Treatment Product Offerings
Table 59. Celgene Corporation Nanotechnology in Cancer Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Nanotechnology in Cancer Treatment Segment by Type in 2021
Figure 2. Nanotechnology in Cancer Treatment Segment by Application in 2021
Figure 3. Global Nanotechnology in Cancer Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Nanotechnology in Cancer Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Nanotechnology in Cancer Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Nanotechnology in Cancer Treatment Revenue in 2021
Figure 8. By Type - Global Nanotechnology in Cancer Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Nanotechnology in Cancer Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Nanotechnology in Cancer Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Nanotechnology in Cancer Treatment Revenue Market Share, 2017-2028
Figure 12. US Nanotechnology in Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Nanotechnology in Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Nanotechnology in Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Nanotechnology in Cancer Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Nanotechnology in Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Nanotechnology in Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Nanotechnology in Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Nanotechnology in Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Nanotechnology in Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Nanotechnology in Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Nanotechnology in Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Nanotechnology in Cancer Treatment Revenue Market Share, 2017-2028
Figure 24. China Nanotechnology in Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Nanotechnology in Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Nanotechnology in Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Nanotechnology in Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Nanotechnology in Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Nanotechnology in Cancer Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Nanotechnology in Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Nanotechnology in Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Nanotechnology in Cancer Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Nanotechnology in Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Nanotechnology in Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Nanotechnology in Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Nanotechnology in Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Laboratories Nanotechnology in Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Combimatrix Corporation Nanotechnology in Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. GE Healthcare Nanotechnology in Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Sigma-Tau Pharmaceuticals Inc. Nanotechnology in Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Johnson & Johnson Nanotechnology in Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Mallinckrodt Plc Nanotechnology in Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Merck & Company Inc. Nanotechnology in Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Nanosphere Inc. Nanotechnology in Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Pfizer, Inc. Nanotechnology in Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Celgene Corporation Nanotechnology in Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
